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Purpose: To clinically validate the noninferiority of the sequentially optimized recon-
struction strategy (SORS) when compared to the dynamic strategy (DS).
Methods: SORS is a novel perimetry testing strategy that evaluates a subset of test
locations of a visual field (VF) test pattern and estimates the untested locations by
linear approximation. When testing fewer locations, SORS has been shown in computer
simulations to bring improvements in speed over conventional perimetry tests, while
maintaining acquisition at high-quality acquisition. To validate SORS, a prospective clini-
cal studywas conducted at theDepartment of Ophthalmology of BernUniversity Hospi-
tal, over 12 months. Eighty-three subjects (32 healthy and 51 glaucoma patients with
early to moderate visual field loss) of 114 participants were included in the study. The
subjects underwent perimetry tests on anOctopus 900 (Haag-Streit, Köniz, Switzerland)
using the G pattern with both DS and SORS. The acquired sensitivity thresholds (ST) by
both tests were analyzed and compared.
Results: DS-acquired VFs were used as a reference. High correlations between individ-
ual STs (r≥ 0.74), as well as betweenmean defect values (r≥ 0.88) given byDS and SORS
were obtained. The mean absolute error of SORS was under 3 dB with a 70% reduc-
tion in acquisition time. SORS overestimated healthy VFs while slightly underestimat-
ing glaucomatous VFs. Qualitatively, SORS acquisition yielded VFwith detectable defect
patterns, albeit some isolated and small defects were occasionally missed.
Conclusions: This clinical study showed that for healthy and glaucomatous patients,
SORS-acquired VFs sufficiently correlated with the DS-acquired VFs with up to 70%
reduction in acquisition time.
Translational Relevance: This clinical study suggests that the novel perimetry strategy
SORS could be used in routine clinical practice with comparable utility to the current
standard DS, whereby providing a shorter andmore comfortable perimetry experience.
Introduction
Perimetry, also known as visual field testing,
plays a central role in the clinical diagnosis and
follow-up of glaucoma.1 Perimetry evaluates the
visual function of the examined eye by consider-
ing the central and peripheral field of view. Perime-
try determines sensitivity thresholds (ST) at prede-
fined retinotopic locations, leading to a functional
map called a visual field (VF). Compared to an
age-matched normative database of normal healthy
subjects, sensitivity thresholds of a visual field are
helpful for detecting abnormalities and losses in visual
function due to glaucoma and other neuro-ophthalmic
diseases.2–6
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Perimetry is usually performed via a query-response
procedure where the patient is presented with sequen-
tial light stimuli of different intensities at different
locations of the visual field while fixing their gaze on a
central fixation point. Patients are then asked to press
a button each time they perceive light stimulus. The
test can be lengthy in time, which can make it uncom-
fortable and can induce fatigue effects and concen-
tration lapses. These negative factors correlated with
higher false-positive/-negative response rates, rendering
the examination results unreliable.7–9
To speed up visual field testing, several alterna-
tive perimetry strategies have been proposed in the
literature, some of which have been adopted into
routine clinical use. Early methods focused on improv-
ing testing speeds by reducing the number of presen-
tations at one VF location through the use of various
techniques that dynamically change light intensity
stimuli based on past patient responses.1,10–14 Such
strategies sped up tests by up to 50% to 80% compared
to conventional perimetry test strategies that take up
to 15 minutes per eye. Other techniques looked for
speed gains by estimating the starting light intensity at
a next query location and thereby reducing the number
of stimuli presented per location. Dynamic strat-
egy (DS),10,15 Swedish interactive threshold algorithm
(SITA) standard,16,17 SITA fast,12,18 SITA faster,19,20
and tendency-oriented perimetry (TOP)21 are examples
of such methods. DS uses a staircasing approach as
also found in conventional techniques but with an
adaptive step whose size depends on the steepness
of the probability of seeing curve (POSC). With this
approach, DS reduces the examination time to almost
5 minutes, with a slight compromise in the VF preci-
sion.22 TOP brings larger reduction in examination
times (e.g., less than two minutes) by exploiting the
correlations within nearby VF locations.21 Although
DS can still be long for some patients to perform
and TOP is used as an alternative, TOP-acquired VFs
unfortunately suffer from lack of precision.23 SITA
standard and SITA fast are a family of algorithms
that combine Bayesian and staircasing approaches and
reduce the examination duration to approximately five
to six minutes.12,17 Although SITA strategies provide
a good accuracy-speed tradeoff, an implementation
of a SITA-like method was shown to perform poorly
when the initial stimulus is over- or underestimated.24
A recent version of SITA strategies, SITA faster, was
designed by introducing seven modifications to SITA
fast and, hence, was reported to take 2.8 minutes
in average providing similar VF quality with SITA
fast.19
More recently, methods have looked to model the
relationship between VF locations in more comprehen-
siveways using graph-based approaches.Globally, such
methods have demonstrated improvements in accuracy,
time, or both.25–28 However, these methods do not
appear to bring speed improvements25,26 or do so only
on healthy patients27 and have limited performance
improvements because of a large number of parame-
ters that must be tuned beforehand.28
Sequentially optimized reconstruction strategy
(SORS)29 proposes to query a subset of test locations
available in the VF pattern and estimate the untested
locations by linear approximation, exploiting the
correlations between the tested and untested locations.
In simulation, SORS was shown to improve speed
compared to several strategies, including the clinically
used DS and TOP without compromising precision.
The purpose of this study was therefore to demon-
strate the clinical reliability of SORS-acquired VFs by
evaluating SORS on both normal healthy subjects and
glaucomatous patients. Because DS is one of the most
frequently used perimetry tests and the most used one
for the often-used Octopus perimeters (Haag-Streit,
Köniz, Switzerland), this study specifically aims at
demonstrating the noninferiority of SORS-acquired
VFs compared to DS within absolute, reduced exami-
nation time.
Methods
In this study, we performed a quantitative prospec-
tive randomized single-center study in the Depart-
ment of Ophthalmology, Bern University Hospital
from October 2018 to July 2019. VFs were collected
and stored in a secure, web-based electronic data
capture tool. The data was anonymized for further
data processing and analysis. The study protocol was
approved by Bernese Ethics Committee, Bern, Switzer-
land, and adhered to the tenets of the Declaration
of Helsinki. Informed consent was obtained from the
subjects about the study procedure.
Subjects
Patients were recruited in a glaucoma outpatient
clinic at the Department of Ophthalmology, Bern
University Hospital. The general inclusion criteria
were an age between 40 and 80 years, refractive error
within ±5 diopter spherical equivalent, an astigma-
tism less than −3 diopter, a visual acuity of more
than 0.3 log Mar, a history of at least one perime-
try examination and less than 20% false-positive and
-negative errors for both DS and SORS examina-
tions. Healthy subjects had mean defects (MD) of
Downloaded from tvst.arvojournals.org on 02/01/2021
Comparative Study (SORS vs. DS) TVST | December 2020 | Vol. 9 | No. 13 | Article 3 | 3
Table 1. Age,MD, and sLV Statistics of the Patient Data Collected in the Study, AlongWithMean, SD, andMax/Min
Values
No. of Patients Age (Mean/SD [Min., Max.]) MD (Mean/SD [Min., Max.]) sLV (Mean/SD [Min., Max.])
Healthy 32 65.31/9.87 [41.41, 80.93] 1.36/1.23 [−0.70, 4.30] 2.48/0.76 [1.60, 4.80]
Glaucoma 51 67.40/8.43 [42.78, 80.93] 5.75/2.76 [0.50, 12.30] 5.67/2.12 [1.90, 11.90]
All 83 65.31/9.87 [40.41, 80.93] 4.06/3.14 [−1.70, 12.30] 4.44/2.32 [1.60, 11.90]
Test-retest 10 66.28/10.00 [41.41, 80.33] 3.32/2.85 [−0.70,9.00] 3.32/1.30 [1.60, 6.00]
less than 2 dB; glaucomatous subjects were diagnosed
with either primary open-angle, pseudoexfoliation
or primary angle-closure glaucoma, with early to
moderate visual field loss (+2 dB < MD < +12
dB). Exclusion criteria were the inability to follow
the procedure, insufficient knowledge of the project
language (German or French), no history of ocular
diseases other than glaucoma or cataract, or any
other visual pathway conditions that might affect
visual field testing (e.g., pituitary lesions, demyelinating
diseases).
Overall, 114 subjects were enrolled in this study,
83 of them (32 healthy and 51 glaucoma) met the
quality criteria (i.e. false positive and negative errors
each less than 20% in each of the SORS andDS exami-
nations) and were included in the study. Moreover, a
randomly selected sub-group of 10 enrolled subjects
(four healthy, six glaucoma) were tested twice with both
DS and SORS in addition to the main study proto-
col to perform a test-retest analysis. Table 1 summa-
rizes the age, MD and square-root loss variance (sLV)
of the included participants, as well as the test-retest
subgroup.
Visual Field Acquisition
Subjects meeting the inclusion criteria were asked to
undertake an additional VF SORS examination during
the same visit of their scheduled DS perimetry exami-
nation appointment. VFs of both eyes were collected
using DS and one randomly determined study eye
was tested using SORS. Both perimetry strategies used
the G program with 59 locations within 30° field of
view. For a given participant, all examinations were
conducted by the same person on the same Octopus
900 Perimeter (Haag-Streit, Inc. Köniz, Switzerland).
The order of DS and SORS tests was randomized
to avoid fatigue or other biases. Patients were given
a mandatory break of five minutes between DS and
SORS examinations. Eye tracking and blinking control
was turned off for all examinations.
For the collection of test-retest data, second exami-
nations were performed less than six months following
the first, with the identical experimental setup as previ-
ously described. That is, we assumed no significant
change related to disease progression betweenmeasure-
ments collected less than six months apart.
SORS: A Brief Description
SORS relies on the assumption that VF locations
tested during a perimetry examination are linearly
dependent to each other. Given this, a VF can be
“reconstructed” by testing only a few locations and
then estimating the untested locations based on the
correlations between tested and untested locations.
In practice, SORS first learns what locations should
be tested and what reconstruction weights should be
used to produce precise VFs. Using a training dataset
of VFs (see next sections) SORS learns the testing
location ordering and the corresponding reconstruc-
tion weights. This is achieved by iteratively solving
a least squares problem, in a greedy and sequen-
tial fashion (see Kucur and Sznitman29 for more
details). In practice, this yields for every untested
location a distinct set of weights associated to tested
locations. Figure 1 illustrates these weights for three
different locations (shown with pink star) after 20, 36,
and 59 location are tested. Asmore locations are tested,
we observe that most of the weight mass is focused
near the location to reconstruct, indicating that local
neighbors provide most of the information. In cases
where few locations are tested, however, we see that
the algorithm establishes weight magnitudes that do
not necessarily depend on the distance between the
locations, but rather their correlative nature defined by
the least squares optimization.
Once the learning phase is complete, a perime-
try examination can be performed on new subjects
by testing locations in the order learned during
the training phase and reconstructing the entire
VF after each new tested location. This involves
computing the threshold value of the entire VF by
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Figure 1. Color-codedweightmaps corresponding to different number of tested locations. Each row corresponds to one location (pink) for
which the reconstruction weights are shown. Columns correspond to the learned weight maps for 20, 36, and 59 tested locations. Untested
locations are locations shown in gray.
multiplying the weight values and the measured thresh-
olds at tested locations. Note that all VF locations,
including measured locations, are thus weighted using
the learned weights.
Implementation Details
SORS was implemented using the Open Perime-
try Interface (OPI).30 Both DS and SORS were run
on the same Octopus 900 perimeter. We used the DS
strategy provided by the manufacturer and available in
the official software EyeSuite. DS measures each visual
field location using adaptive staircasing and stops at the
first response reversal.10,15 It also interpolates the inter-
mediary estimations to adjust starting STs for the next
query.
To learn the SORS reconstruction weights, we used
a training dataset of visual fields from the BernUniver-
sity Hospital. This dataset consisted of 1168 G pattern
VFs from glaucoma and normal healthy patients
(potentially contained patients with other diseases), all
acquired with the normal strategy.22 The mean MD
in the training dataset was of 4.88 (standard devia-
tion [SD] = 5.87, min.-max. range [−7.82, 27.11]) and
the mean sLV of 3.86 (SD = 2.33, min.-max. range
[1.22,12.61]).
As in DS, our SORS implementation used the
dynamic staircasing method to measure individual
locations. To account for the reduced precision of
dynamic staircasing compared to the 4-2 staircasing
of the normal strategy, we simulated each VF in
the training dataset 10 times with dynamic staircas-
ing using OPI.30 This resulted in 10 noisy versions
of a correct VF (we assume that the VFs acquired
with normal strategy are the true VFs), leading
to a noisy training dataset that was subsequently
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used to learn the SORS locations and reconstruction
weights.
SORS uses the same staircasing scheme and “one
reversal” stopping criterion as in DS. Testing of
locations are then performed in the order found during
the training phase. Each time a location is completely
queried, an intermediary reconstruction of the VF (i.e.,
estimation for the VF) is made. The starting stimulus
intensity of a new location is set to the estimated value
by the previous VF estimation.
In its original version, SORS queried each location
until one reversal and followed the order of testing
found during the training phase. However, this did not
distribute the spatial attention of subjects, which has
been shown to result in increased sensitivity measure-
ments.31–33 Instead, we adapted SORS such that a pool
of four locations is randomly queried and when one
location is completely queried, a next location from
the testing order is included into the pool replacing
the finished location. For the first four locations in the
testing pool, the starting stimulus intensity was set to
the normative value from the age-matched population
and for the upcoming locations, they were set to the
value from the previous VF reconstruction as afore-
mentioned.
For both methods, standard background luminance
of 31.4 asb (10 cd/m2) was used, and maximum
stimulus luminance was 4000 asb following Octopus
900 standards. Moreover, stimulus size was set to
Goldman size III, and a white-on-white stimulus type
was used. Stimulus duration was 100 ms, and the
response window was 2000 ms. False-positive and -
negative catch trials were randomly presented to the
patient, representing up to 10% (each 5%) of the
total stimuli presentations. Fixation of subjects was
manually monitored, and subjects were encouraged to
keep their gaze fixed at the target during the examina-
tion. In case of fixation loss, the test was paused until
fixation was regained. Patients were also able to stop
and take breaks during both the DS and SORS exami-
nations.
To better assess the SORS performance at every
reconstruction step, SORS measured all of the 59
test locations and the intermediary VF estimates were
stored for each VF. Hence, the performance evolu-
tion with respect to the number of tested locations
could be evaluated after the examination and the effec-
tive number of test locations to be queried could be
properly determined.
Data Analysis/Statistics
To evaluate the correlation of DS and SORS, we
computed correlation plots of thresholds of individ-
ual locations as well as MD values measured/estimated
by DS and SORS. The correlation coefficient, r, which
measures the goodness of the fit, is provided alongside
as well. Specifically, r takes values between −1 and 1,
where 1/−1 indicates strong positive/negative relation-
ships, whereas values closer to 0 suggests weak or no
relationship.
Estimation biaswas also evaluated for bothmethods
by means of histograms of differences between thresh-
olds and MDs measured by DS and SORS estimates.
The mean of the distributions is ideally 0 for an
unbiased method.
Mean absolute error (MAE) performance of SORS











where VFn,l is the ST at the lth test location of the VF
belonging to nth patient. We show MAE performances
with respect to the number of locations tested by SORS
or the corresponding number of presentations.
Examination duration was compared across both
methods as well as the number of tested locations by
SORS. To further assess the time performances, we
provide total number of stimuli presentations for SORS
results with 20, 36, and 59 (all) compared to the DS
results with 59 stimuli. Average number of presented
stimuli per location was also computed to evaluate the
gain in terms of time.
Test-retest variability analysis was performed for
DS and SORS on a sub-population of subjects. This
analysis has two purposes: (1) Comparison of test-
retest variability of both techniques; (2) Assessment of
the noninferiority of SORS compared to DS. For this
purpose, histograms of differences and Bland-Altman
plotswere used to show whether the difference between
DS and SORS measurements are within the range
of DS test-retest variability and to inspect the SORS
range of test-retest variability.
Qualitative VF examples were also provided to
compare resulting VF estimates with DS measured
VFs. Error performance with respect to a gradient
measurewas additionally presented for a deeper under-
standing of the SORS performance on estimating the
isolated defects.
Results
Figure 2 shows the individual threshold correla-
tions, as well as the correlation between measured
MDs from DS and SORS acquisition after testing 20,
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Figure 2. Correlations between individual thresholds and MDs measured by DS and estimated by SORS testing 20 (a, b), 36 (c, d) and all
(59) locations (e, f ). The number of locations tested by SORS (i.e., S) and the r values with the corresponding P values are given on each plot.
Red dotted line corresponds to the best fit line of the data points.
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Figure 3. Correlations between individual thresholds acquired by both methods for tested (a, c) and untested locations (b, d) with 20 (a,
b) and 36 (c, d) SORS tested locations. The number of locations tested by SORS (i.e., S) and the r values with the corresponding P values are
given on each plot. Red dotted line corresponds to the best fit line of the data points.
36, and all (59) locations. r values for correlation in
threshold measurements are 0.737, 0.746 and 0.789
for SORS testing 20, 36, and 59 locations, respec-
tively (Wald test, p < 0.0001). r values for correla-
tions in MD measurements are 0.888, 0.912, 0.927 for
20, 36 and 59 locations, respectively (Wald test,
p < 0.0001). Additionally, we present the correlations
for tested and untested locations separately for testing
20 and 36 locations in Figure 3.
Figure 4 shows the difference distributions in
individual ST values from SORS and DS on healthy
and glaucoma subgroups. In general, SORS estimated
on average the healthy group thresholds slightly higher
than DS when testing 20, 36 and 59 VF locations.
Conversely, SORS marginally overestimated thresh-
olds in the glaucoma group, but with mean differences
below −0.1 dB across the evaluated tested location
amounts. Similarly, Figure 5 shows the MD estima-
tion bias: MDs estimated by SORS were lower than
those measured by DS for both healthy and glaucoma
groups with values below 1 dB across evaluated test
amounts.
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Figure 4. Estimation bias on assessing individual thresholds when SORS testing 20 (top row), 36 (middle row), and 59 (bottom row) for the
healthy (left column) and for the glaucoma (right column) groups. Mean and SD, as well as the number of tested locations (i.e., S), are given
on each plot.
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Figure 5. Estimationbias onMDmeasurementwhen SORS testing 20 (top row), 36 (middle row), 59 (bottomrow) for the healthy (left column)
and for the glaucoma (right column) groups. Mean and standard deviations (SD) as well as the number of tested locations (i.e., S) are given
on each plot.
Downloaded from tvst.arvojournals.org on 02/01/2021
Comparative Study (SORS vs. DS) TVST | December 2020 | Vol. 9 | No. 13 | Article 3 | 10
Figure 6 depicts the relation between patient age
and MD estimation bias, with a general increase in
result variance with age. In addition, regardless of
the number of VF tested locations, SORS estimated
MD values lower than DS for the 80+ age range. To
better assess any systematic error for particular thresh-
old ranges, we show absolute errors with respect to the
individual threshold values in Figure 7. Accordingly,
the error was found to be higher at both extreme ends
of the range.
Figure 8 shows the error performance of SORS
with respect to the number of presentations used,
with DS thresholds taken as gold standard. MAE
for healthy subjects were on average lower than
for glaucoma patients, regardless of how many VF
locations were tested. Over both subgroups MAEs
of 3.17 (SD = 1.30), 3.00 (SD = 1.15), 2.92 (SD =
1.09) were found when testing 20, 36, and 59 locations,
respectively.
With respect to the test-retest performance, Figure 9
shows that estimation biaswhen observing all ST values
(N = 590, 10 subjects each with 59 locations). For each
case (DS vs. DS, SORS vs. DS, and SORS vs. SORS),
the mean bias was under 1 dB and the standard devia-
tion was no larger than 3.7 dB. Figure 10 shows Bland-
Altman difference plots for all comparison combina-
tions, with the middle line corresponding to the mean
difference and the upper and lower lines corresponding
to 95% limits of agreements.
Median duration values with confidence intervals
for observed locations are provided for healthy and
glaucoma group, as well as all patients in Table 2.
Medians were found to be significantly different from
each other (Kruskal-Wallis test, P < 0.0001). A similar
comparison is made with respect to the total number
of presentations presented by SORS and DS, where
medians were found to be significantly different to one
another (KruskalWallis test,P< 0.0001).When testing
both methods with 59 locations (i.e., all locations), the
mean number of stimuli presentations per location by
SORS was significantly lower than DS (SORS, 2.36
[SD= 0.18];DS, 2.48 [SD= 0.20];Mann-Whitney rank
test, P < 0.0001).
Qualitatively, Figures 11 and 12 illustrate three VF
examples from healthy and glaucoma groups, respec-
tively. For each example, SORS VF acquisitions after
testing 20, 36, and 59 locations are given and compared
to the corresponding DS acquisition. For reference,
MAE values are shown for each acquisition.
Since glaucoma can manifest itself as isolated
defects, i.e., a small region can worsen more sharply
than its neighboring locations, it is crucial for a perime-
try strategy to identify such local defect regions as
accurately as possible. Therefore, to evaluate SORS
performance at measuring isolated defects, Figure 13
Figure 6. Estimation bias on MD estimation with respect to the
age of the patient when the number of locations tested by SORS are
S = 20 (top), S = 36 (middle), and S = 59 (bottom). For each subplot,
Kruskal-Wallis test is performed, and P values are accordingly given.
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Figure 7. Differences in sensitivity thresholds as a function of DS measured sensitivity threshold: (a) 20 and (b) 36 SORS tested locations.
Figure 8. SORS performance in terms of accuracy and time. MAE and mean number of stimuli presentations are given with respect
to the number of locations for all (left column), healthy (middle column), and glaucoma patients (right column). Error bars correspond to
the SDs.
presents absolute errors with respect to a gradi-
ent measure l = max
ln∈Nl
|STl − STln | computed at the
location l,25,29 where Nl is the set of neighboring
locations (within a radius of 9°).l corresponds to the
highest difference between the ST at location l. A high
l indicates the location l’s ST is significantly different
to its neighbor(s) (i.e., less homogeneous region) and is
more challenging to predict. In Figure 13, we show the
pooled errors with respect to l at all locations from
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Figure 9. Histograms of threshold differences on test-retest sub-population. Columns correspond to SORS vs. DS, DS vs. DS, and SORS vs.
SORS cases, respectively. Rows correspond to cases where SORS tested 20, 36, and 59 (all) locations, respectively. The counts are normalized.
Mean and SDs are provided in the legends.
all healthy and glaucoma patients for the cases where
20 and 36 locations are tested by SORS.
Discussion
SORS achieved good correlations with DS in terms
of individual thresholdmeasurement evenwhen testing
only 20 locations with r values higher than 0.7. As
expected, the correlation improved when increasing the
number of SORS tested locations, and was consis-
tent with the results shown in simulation.29 Reported
r values for the correlation of MD values between DS
and SORS remained very high even when the number
of test locations was reduced to a third (see Fig. 2).
Moreover, Figure 3 shows that the correlation for tested
and untested locations hardly differed from each other.
This also demonstrates the strength of our proposed
model that could learn to interpolate untested locations
as successfully as for tested locations.
Considering the error distributions reported
in Figure 4, the results indicate a slight overestimation
of thresholds, and yielding lower MDs by SORS. This
overestimation however is negligible with values of less
than 1 dB. For glaucoma subjects though, the error
distribution had larger variance which is consistent
with reported VF studies.20,34 As for the error distri-
bution in MD estimation with respect to patient age
(see Fig. 6), the SORS appears to have no significant
dependency on the patient age (Kruskal-Wallis test,
P > 0.1).
As given by Figure 7, SORS overestimated the STs
less than 20 dB and slightly underestimates larger STs.
The error got more remarkable for lower threshold
range, especially for those less than 13 dB. One should,
however, note that the bias in the low range was not
significant because only patients with MD > 12 dB
were included. Thus, not only were there few locations
with low STs, the reliability of these is known to be
low.35 Therefore we cannot deduce a strong conclusion
regarding SORS’ estimation bias for the range below 15
dB. For STs greater than 15 dB, however, we conclude
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Figure 10. Bland-Altman agreement graphs for SORS vs. DS, DS vs. DS, and SORS vs. SORS for SORS testing 20, 36, and 59 (all) locations
given row-wise. The black dotted line corresponds to themean difference, and red dotted lines correspond to 95% limits of agreements (mean
± 1.96 SD). Light-gray areas are confidence intervals on the mean and limits of agreements.
that SORS slightly tended to overestimate above 20 dB
and underestimated below, but that the error remained
mainly within a [−5, 5] dB range.
Considering MAE performance for all patients, the
MAE was less than 3.3 dB after 14 locations tested
(MAE: 3.27 [SD = 1.38 dB], mean number of presen-
tations: 35.37 [SD = 3.39]) and is 3.17 dB (SD = 1.30)
when testing 20 locations (mean number of presen-
tations being 52.06 [SD = 4.69]). For the healthy
group, the MAE was of mean 2.02 dB (SD = 0.49
dB) with number of stimuli presentations of mean
40.10 (SD = 3.77) when observing 16 locations. This
is expected because healthy VFs are smooth, which
can be easily inferred without queryingmany locations.
The gain with additional tested locations was higher in
the glaucoma group as the MAE performance contin-
ued to improve with the number of tested locations,
although the improvement was still much higher for
the first test locations. The MAE was under 4 dB for
20 locations (MAE = 3.90 [SD = 1.08]), with 50.04
(SD = 5.06) stimuli presentations and was less than 3.7
for 36 locations (MAE = 3.62 [SD = 0.97]), with 87.86
(SD = 7.95) stimuli presentations, which is within the
acceptable range for VF accuracy.
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Table 2. TheMedian Values [Min.,Max.] for theNumber of Stimuli Presentations and for the ExaminationDuration
by SORS Testing 20, 36, and 59 (All) Locations Compared to DS Testing 59 (All) Locations
No. of Tested Locations
20 36 59 (All)
No. of stimuli presentations
All patients
SORS 49 (48–49) 85 (84–87) 137 (135–139)
DS — — 145 (141–149)
Healthy
SORS 49 (47–52) 85 (83–87) 133 (131–137)
DS — — 138 (134–140)
Glaucoma
SORS 49(48–50) 86 (85–88) 138 (136–143)
DS — — 152 (148–155)
Examination duration (mins)
All patients
SORS 2.06 (2.01–2.12) 3.62 (3.56–3.67) 5.79 (5.71–5.89)
DS — — 6.07 (5.87–6.22)
Healthy
SORS 2.06 (2.01–2.15) 3.57 (3.52–3.64) 5.63 (5.57–5.78)
DS – – 5.75 (5.57–5.83)
Glaucoma
SORS 2.06 (2.02–2.12) 3.66 (3.56–3.75) 5.90 (5.74–6.06)
DS — — 6.33 (6.17–6.50)
95% confidence interval for each distribution is given in parentheses.
To further verify if the difference between DS and
SORS measurements is within acceptable range, the
performed test-retest experiments on a sub-group of
10 patients show some indication in this direction.
By quantifying the test-retest variability, we compared
the intrinsic variability of DS and SORS and evalu-
ated whether the deviation of SORS thresholds from
those of DS remained within test-retest variability
range. As shown in Figure 9 and in Figure 10, test-
retest variability of SORS was found to be smaller
than DS as the standard deviations and limit of agree-
ments for SORS test-retest differences were smaller
than those for DS. This suggests that SORS measure-
ments are reliable enough to decouple glaucomatous
progression from measurement variation. Moreover,
the variation between SORS and DS was similar (even
smaller) than DS test-retest variability, as illustrated by
the standard deviation and limits of agreement lines.
This points to noninferiority of SORS compared to
DS. These findings, however, should be taken with
care because the test-retest analysis could only be
performed on a subgroup of 10 patients. A larger test-
retest clinical study is therefore needed for a definite
conclusion.
Examination duration was two minutes with SORS
testing 20 locations, which is one third of the exami-
nation duration of DS (see Table 2). This is significant
for the healthy group because SORS performed very
well testing only 16 locations (MAE≈ 2 dB, see Fig. 8).
This demonstrates that the examination can be reduced
to almost under two minutes without noticeably affect-
ing the VF accuracy for healthy patients. By testing
36 locations (MAE ≈ 3.7 dB, see Fig. 8), SORS led
to more than 40% of time reduction compared to
DS for both control and glaucoma patients. Inter-
estingly, SORS testing all (59) locations had a 5%
gain in the speed of the examination, even though
they both share an adaptive staircasing scheme and
stopping criterion (i.e., one reversal). This is likely due
to SORS’ method to select starting intensity values
being closer to the real ST so that locations terminate
faster with fewer stimuli per location. This was also
observed with the total number of stimuli, as well as
the average number of stimuli presented per location,
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Figure 11. Three healthy visual fields examples. Each row shows acquisition output of a patient’s VF for SORS with 20, 36, 59 locations
tested as well as for DS. The respective method, the numbers of tested locations, and the MAEs are given above each image.
which are found to be significantly less for SORS than
for DS.
In general, healthy VFs appeared smooth with
relatively small acquisitions MAEs (see the qualita-
tive examples shown in Fig. 11). Interestingly, SORS
appeared to be performing well early on, when testing
few locations (e.g., 20 locations) and little qualita-
tively and quantitatively improvements thereafter. This
coincides with the stagnant error performance after
testing 16 locations (see Fig. 8). In the glaucoma VF
examples, the MAEs were higher because of hetero-
geneous defect patterns in each example in Figure 12.
SORS could detect defect regions in those VFs, even
with 20 locations, even though the VFs appeared
smoother than those acquired with DS. This smooth-
ness is a direct consequence of the linear model
used to reconstruct missing VF locations and can
lead to missing some isolated defects as in Patient D
in Figure 12. While being inevitable, the induced
smoothness by SORS did not significantly affect the
prediction of the isolated defects as the error of predict-
ing highly gradient region was mostly less than 5 dB
even for very high l values (e.g. 15 dB < l < 25 dB,
see Fig. 13). This finding ensures that SORS, testing a
fewer number of test locations, is able to capture, on
average, isolated defects up to a reasonable precision,
while individual counterexamples may occur.
A limitation of this study is the fact that we
compared SORS to DS, which is clinically the most
important but not a full threshold method that would
provide more accurate ST measurements. A better
option would be to compare SORS to a normal strat-
egy,22 alongside a test-retest protocol to estimate the
variance in individual ST measurements. A follow-up
study would be necessary to further clinically validate
the SORS algorithm.
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Figure 12. Three glaucomatous visual fields examples. Each row shows acquisition output of the sameVF for SORSwith 20, 36, 59 locations,
as well as for DS. The respective method, the numbers of tested locations, and the MAEs are given above each image.
Figure 13. Absolute error with respect to gradient measure l for SORS testing 20 (a) and 36 (b) locations. Greater l value corresponds
to a location having ST highly differing from its surrounding.
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Conclusion
SORS is a novel perimetry test strategy that queries
fewer test locations than current conventional strate-
gies used clinically in glaucoma care. It exploits the
existing correlations between test locations and accord-
ingly makes dynamic estimates of the VF during the
examination using newly tested locations. This study
has shown that SORS can achieve precise VF acquisi-
tions, comparable to a conventional clinical technique,
DS, in 40% to 70% less time. Shorter SORS exami-
nations (i.e., testing fewer locations), seem to yield
smoother VFs with potential subtle defects being
missed. Nonetheless, SORS provides a good accuracy-
speed tradeoff, whereby being a flexible and adaptable
to any pattern and compatible with any staircasing
scheme. SORS could therefore be potentially benefi-
cial to use in routine clinical use for early to moderate
glaucomatous patients.
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